Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AMLODIPINE\CANDESARTAN CILEXETIL for Secondary progressive multiple sclerosis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 28 adverse event reports in the FDA FAERS database where AMLODIPINE\CANDESARTAN CILEXETIL was used for Secondary progressive multiple sclerosis.

Most Reported Side Effects for AMLODIPINE\CANDESARTAN CILEXETIL

Side Effect Reports % Deaths Hosp.
Dizziness 36 39.1% 0 4
Bradycardia 33 35.9% 0 4
Pain 33 35.9% 0 4
Anxiety 30 32.6% 0 1
Fall 30 32.6% 0 1
Nocturia 30 32.6% 0 1
Pollakiuria 30 32.6% 0 0
Ataxia 29 31.5% 0 0
Balance disorder 29 31.5% 0 0
Central nervous system lesion 29 31.5% 0 0
Dysarthria 29 31.5% 0 0
Erectile dysfunction 29 31.5% 0 0
Gait spastic 29 31.5% 0 0
Hypertonic bladder 29 31.5% 0 0
Hypoaesthesia 29 31.5% 0 0

Other Indications for AMLODIPINE\CANDESARTAN CILEXETIL

Hypertension (34) Product used for unknown indication (19)

Other Drugs Used for Secondary progressive multiple sclerosis

SIPONIMOD (2,265) OCRELIZUMAB (1,273) OFATUMUMAB (1,099) FINGOLIMOD (351) INTERFERON BETA-1B (146) RITUXIMAB (131) NATALIZUMAB (115) DIMETHYL (96) INTERFERON BETA-1A (89) RABEPRAZOLE (86)

Related Pages

AMLODIPINE\CANDESARTAN CILEXETIL Full Profile All Secondary progressive multiple sclerosis Drugs AMLODIPINE\CANDESARTAN CILEXETIL Demographics AMLODIPINE\CANDESARTAN CILEXETIL Timeline